PharmTech LCGC Sciex Webinar 11.10
|Articles|February 2, 2009

CE-MS and Coronary Artery Disease Diagnosis

Researchers from Germany, Belgium, the UK, and Australia conducted a study of urine from patients with and without coronary artery disease to look for proteome patterns indicative of the disease.

Researchers from Germany, Belgium, the UK, and Australia conducted a study of urine from patients with and without coronary artery disease to look for proteome patterns indicative of the disease. They used capillary electrophoresis coupled with mass spectrometry (CE–MS) to analyze the urine samples. They examined a combination of 17 polypeptides and found specific polypeptide patterns in the urine that were associated with coronary artery disease in patients with angina. They suggest that further studies are necessary to evaluate the clinical value of the CE–MS urine proteome analysis for diagnosis of coronary artery disease.


Related to this article

Best of the Week: From Cancer Diagnostics to Smarter LC Method Development
This week, Chromatography Online’s coverage spanned lipidomics-based early cancer detection, career paths in separation science, machine learning and uncertainty-driven approaches to LC method development, new EU wastewater rules for pharmaceutical micropollutants, automated Separation Quality Factor (SQF) evaluation in chromatography data systems, and solutions to GLP-1 peptide analysis challenges.